• Chemiluminescent Substrate Kit for Omics Validation

  2026-08-13

  The ECL Chemiluminescent Substrate Detection Kit connects multi-omics discoveries with practical membrane-based validation. This article explains how HRP-luminol chemistry can support protein detection by ECL, pathway-focused assay design, and careful interpretation of migraine research findings.

• Atropo-Enantioselective Suzuki Synthesis of a Biaryl

  2026-08-13

  Herrbach and colleagues reported a catalytic asymmetric route to an axially chiral biaryl related to the antimitotic natural product rhazinilam. The study’s central advance was an intermolecular Suzuki coupling that used a chiral binaphthyl phosphine to form the nonbridged biaryl precursor with up to 40% enantiomeric excess, establishing a practical precedent for asymmetric synthesis of biologically relevant atropisomers.

• Angiotensin I: RAS Workflows and Assay Tips

  2026-08-12

  Angiotensin I is a versatile precursor substrate for mapping ACE activity, modeling renin-angiotensin system signaling, and screening antihypertensive compounds. This workflow-focused guide also explains why intact Angiotensin I should be separated from shorter angiotensin peptides when interpreting receptor-binding or antiviral assays.

• Pexmetinib (ARRY-614): A Translational Edge

  2026-08-12

  Pexmetinib (ARRY-614) offers a translational framework for studying inflammatory cytokine inhibition through coordinated targeting of p38 MAPK and Tie2. This article connects cellular and clinical research considerations with emerging structural insight into kinase conformational control.

• AR Antagonists Against Resistance: Study Analysis

  2026-08-11

  This 2025 Journal of Medicinal Chemistry study identifies Y5 as a potent antiresistance androgen receptor antagonist designed to bind the AR dimer interface pocket rather than the conventional ligand-binding pocket. Its dual mechanism—disrupting AR dimerization and promoting ubiquitin-proteasome-mediated AR degradation—supports further investigation in drug-resistant prostate cancer models.

• METTL16–SENP3–LTF Axis in HCC Ferroptosis

  2026-08-11

  Wang et al. identify METTL16 as an m6A-linked suppressor of ferroptosis in hepatocellular carcinoma and define a METTL16–SENP3–LTF axis that limits iron-dependent lipid peroxidation. The study combines molecular assays, organoids, xenografts, genetically modified mice, and human samples, providing a mechanistic framework for sensitizing HCC to ferroptosis-based treatment.

• Tobramycin Workflows for Microbiology Research

  2026-08-10

  Tobramycin provides a water-based route to reproducible aminoglycoside susceptibility, mechanism, and resistance assays without relying on DMSO or ethanol. This guide translates a classic comparative microdilution study into practical setup, optimization, and troubleshooting decisions for modern microbiology research.

• METTL16–SENP3–LTF Axis in HCC Ferroptosis

  2026-08-09

  Wang et al. identify a METTL16–SENP3–LTF signaling axis that links m6A-dependent RNA regulation to iron sequestration and ferroptosis resistance in hepatocellular carcinoma. The findings provide a mechanistic framework for studying how altered iron handling supports HCC progression and for designing experiments that test ferroptosis sensitization.

• EdU Imaging Kits (HF594): Practical Workflow

  2026-08-08

  EdU Imaging Kits (HF594) provide a click-chemistry workflow for measuring 5-ethynyl-2’-deoxyuridine incorporation during S-phase, supporting fluorescence microscopy and flow cytometry. They are suited to fixed-cell proliferation and DNA synthesis studies, but should not be treated as a validated live-cell imaging method or used with copper-incompatible downstream workflows without testing.

• Arachidonic Acid Accelerates Vaccine Humoral Immunity

  2026-08-07

  Feng and colleagues show that dietary arachidonic acid can strengthen rabies vaccine responses by increasing neutralizing antibodies and improving protection in mice, while also accelerating protective antibody development in human volunteers. The study links this effect to lymph-node lipid metabolism, prostaglandin I2 signaling, CD86 expression, and activation-induced cytidine deaminase in B cells.

• (-)-Blebbistatin: Precision Non-Muscle Myosin II Inhibitor W

  2026-08-07

  (-)-Blebbistatin stands apart as a selective, reversible non-muscle myosin II inhibitor, enabling high-precision manipulation of cytoskeletal dynamics across cell biology and cardiac research. This guide delivers actionable protocols, advanced troubleshooting, and bridges reference study insights to experimental design—empowering rigorous, reproducible research.

• JNJ-10198409: Optimizing PDGF Receptor Inhibition in Researc

  2026-08-06

  JNJ-10198409 offers precise, ATP-competitive inhibition of the PDGF-BB receptor, enabling robust suppression of tumor growth and angiogenesis in vitro and in vivo. This guide details workflow enhancements, troubleshooting strategies, and protocol parameters that maximize reproducibility for cancer biology and fibrotic disorder research.

• (S)-Mephenytoin in Cytochrome P450 Metabolism: Precision, Pi

  2026-08-06

  (S)-Mephenytoin is a gold-standard CYP2C19 substrate for oxidative drug metabolism studies. This article uniquely explores assay optimization, protocol design, and the practical impact of stem cell-derived organoid innovations for translational pharmacokinetics.

• Homoharringtonine Rapidly Clears SARS-CoV-2 in URT Models

  2026-08-05

  The referenced study demonstrates that homoharringtonine, a cytotoxic alkaloid with established use in leukemia research, achieves rapid clearance of SARS-CoV-2 from the upper respiratory tract in both animal models and clinical settings. This work defines homoharringtonine's translational potential as a first-line antiviral intervention, with significant implications for future coronavirus epidemic preparedness.

• Selective Autophagy Regulates IRF3 Stability in Antiviral Im

  2026-08-05

  Wu et al. (2021) reveal that selective autophagy, mediated by CALCOCO2/NDP52 and regulated by the deubiquitinase PSMD14, controls the degradation and stability of the transcription factor IRF3. This mechanism fine-tunes type I interferon production, balancing antiviral defense and immune suppression, and highlights new regulatory nodes for transcription factor modulation in innate immunity.

15911 records 1/1061 page Next 12345 下5页 Last page